Key result
Postoperative DVT chemoprophylaxis is rarely used in elective spine surgery, with ~2% thrombotic complications without it.
Why the study?
The utilization rate of postoperative DVT prophylaxis and the comparative incidence and severity of bleeding and thrombotic complications in elective spine surgery patients were not well characterized.
Does postoperative DVT chemoprophylaxis affect the incidence of bleeding and thrombotic complications in patients undergoing elective spine surgery?
Observational (n=119,888)
Yes
Does postoperative DVT chemoprophylaxis affect the incidence of bleeding and thrombotic complications in patients undergoing elective spine surgery?
DVT prophylaxis is rarely utilized following elective spine surgery (>99% do not receive it), but targeted prophylaxis may benefit high-risk populations such as those with atrial fibrillation, cancer, or prior thrombosis.
Answers are grounded in this paper and cite their sources.
Routine pharmacologic DVT prophylaxis in elective spine surgery remains contested; leaves open the need for prospective trials to guide risk-benefit decisions.
Study Design: Retrospective, database review. Objectives: Examine the utilization rate of postoperative deep vein thrombosis (DVT) prophylaxis and compare the incidence and severity of bleeding and thrombotic complications in elective spine surgery patients. Methods: We utilized PearlDiver, a national orthopedics claims database. All patients who underwent elective spine surgery from 2007 to 2017 were included. Patients were stratified by the presence of DVT prophylaxis drug codes, then by comorbidities for postoperative bleeding/thrombosis. The severity of all bleeding and thrombotic complications in each cohort was studied, including the incidence of complications requiring operative washout, diagnosis of pulmonary embolism, intensive care unit admission, and mortality. Results: A total of 119 888 patients were included. The majority of patients (118 720, >99%) were not administered postoperative DVT chemoprophylaxis while a minority of patients (1168) were. The overall rates of bleeding and thrombotic complications within the population not receiving DVT prophylaxis were 1.96% and 2.45%, respectively ( P < .001). The incidence of surgical intervention for a wound washout was 0.62% compared with 1.05% for pulmonary embolism ( P < .001). Intensive care unit admission rates related to a wound washout procedure or pulmonary embolism also significantly differed (0.07% vs 0.34%, P < .001). There were no observed differences in mortality. When controlling for patient comorbidity, patients with atrial fibrillation, cancer, or a prior history of thrombotic complications experienced the greatest increased risks of postoperative thrombosis. Conclusions: DVT prophylaxis is not routinely utilized following elective spine procedures. We report that there exist specific populations which may receive benefit from these practices, although further study is necessary to determine optimal prevention strategies for both thrombotic and bleeding complications in spine surgery.
No takes yet. Share an insight, caveat, or question.
Pirkle et al. (2019) conducted an observational in Elective spine surgery (n=119,888). Postoperative DVT chemoprophylaxis vs. No postoperative DVT chemoprophylaxis was evaluated on Bleeding and thrombotic complications. Postoperative DVT chemoprophylaxis was administered to <1% of elective spine surgery patients, while those not receiving prophylaxis had bleeding and thrombotic complication rates of 1.96% and 2.45%.
Synapse has enriched 10 related papers. Consider them for comparative context: